Supervisor Elham AbolFateh
Editor in Chief Mohamed Wadie

WHO: Effective Corona Vaccine Alone Won't Stop Pandemic


Tue 17 Nov 2020 | 05:03 AM
Ahmed Moamar

Today, Monday, the World Health Organization (WHO) confirmed that obtaining an effective vaccine against the novel Coronavirus (COVID-19) will not alone itself stop the spread of the pandemic.

Director-General of WHO Tedros Adhanum Ghebreyesus has tweeted that since the beginning of the COVID-19 pandemic, the organisation knew that developing a vaccine will be vital to controlling the pandemic.

But it is important to stress that the vaccine will complement the other tools that are needed.

"We have it and will not replace it,", he said.

He added that any vaccine will not stop the COVID-19 pandemic in itself.

"But we will have to continue monitoring, conducting examinations, following quarantine and taking care of cases, following-up infections while isolating contacts, engaging communities and encouraging people to exercise caution", he pointed out.

He indicated that the first supplies of a vaccine against COVID-19 will be limited, for this reason, priority will be given to health workers, the elderly, and other groups of people who are considered vulnerable (to the disease).

"We hope that this matter will reduce the number of deaths and enable health systems to contain the situation, but it will remain," he said.

Dr. Ghebreyesus warns that the virus has a lot of room to move.

A wide range of countries, including Russia, the United States, Britain, France, Germany, and China, are locked in a global race to develop effective vaccines against the emerging coronavirus "COVID-19", which has killed more than 1.3 million people around the world.

Currently, Russia is the first country in the world to register a vaccine against the emerging coronavirus, and there are two vaccines at the present time that have been registered in the country.

The first is "Sputnik V" which is developed by the "Gamali" Center for Epidemiology and Microbiology Research, and the second is called "Epivac Corona" which is developed by experts   Victor Research Center for Virus and Biotechnology.